After your last dose of Trelegy Ellipta, the drug’s three active components take roughly 5 to 7 days to fully clear from your system. That range exists because Trelegy isn’t a single drug. It contains three medications, each with a different elimination timeline, and the slowest one determines how long traces remain detectable in your body.
Half-Lives of Trelegy’s Three Components
Every drug is measured by its “half-life,” the time it takes for your body to reduce the blood concentration by half. After about five half-lives, a drug is considered effectively eliminated. Trelegy’s three ingredients have distinctly different half-lives after inhaled dosing:
- Fluticasone furoate (the steroid that reduces inflammation): approximately 24 hours
- Umeclidinium (the component that opens airways by relaxing smooth muscle): approximately 19 hours
- Vilanterol (the long-acting bronchodilator): approximately 11 hours
Vilanterol clears the fastest. At roughly 11 hours per half-life, five half-lives comes out to about 2.5 days. Umeclidinium takes closer to 4 days. Fluticasone furoate is the slowest, needing about 5 days (120 hours) to drop to negligible levels. So if you stop Trelegy entirely, the steroid component is the last to leave, and your body is essentially clear within 5 to 7 days.
How Your Body Eliminates Each Component
The three drugs leave your body through different routes. Fluticasone furoate is eliminated almost entirely through the digestive tract: 90% exits in feces and only about 2% through urine. Umeclidinium splits the difference, with 58% cleared through feces and 22% through urine. Vilanterol takes the opposite path, with 70% eliminated through urine and 30% through feces.
These differences matter because anything that affects your liver or kidneys can shift how quickly each component clears. The liver does much of the metabolic work for fluticasone furoate and vilanterol, while umeclidinium relies on a mix of liver processing and direct excretion.
Why Effects Can Linger After Clearance
Trelegy is designed for once-daily dosing because its components maintain their therapeutic effect across a full 24-hour period. If you’ve been taking it regularly, your body reaches a “steady state” where each new dose tops off what’s still circulating. This means the drug builds up to a consistent level in your tissues over time.
Even after the active ingredients leave your bloodstream, some residual effects can persist. The steroid component, for example, works by suppressing inflammatory pathways in your lungs, and that suppression doesn’t switch off the instant blood levels drop. You may notice a gradual return of symptoms over several days rather than a sudden change.
Factors That Slow Elimination
Several things can keep Trelegy in your system longer than average.
Liver Function
Liver impairment has the biggest impact on fluticasone furoate. People with mild liver problems show about 34% higher blood levels of the steroid, while moderate and severe impairment raise levels by 75% to 83%. That translates to a meaningfully longer clearance time. Umeclidinium and vilanterol are less affected by liver issues.
Kidney Function
Severe kidney impairment increases vilanterol exposure by about 56% compared to people with normal kidney function. Since vilanterol is primarily cleared through urine, reduced kidney function slows that route. Fluticasone furoate and umeclidinium levels are not significantly affected by kidney problems.
Other Medications
Drugs that inhibit a key liver enzyme called CYP3A4 can raise blood levels of two of Trelegy’s components. Strong CYP3A4 inhibitors (common examples include certain antifungal and HIV medications) increased fluticasone furoate exposure by 36% and vilanterol exposure by 65% in clinical testing. If you take one of these medications, both drugs stay active in your system longer than they otherwise would.
Practical Timeline After Stopping
Here’s a realistic picture of what to expect if you stop taking Trelegy. Within the first 24 hours, vilanterol levels drop significantly and its bronchodilating effect begins to fade. By 48 to 72 hours, umeclidinium is largely cleared and you’ll likely notice more airway tightness. By day 5 to 7, fluticasone furoate has fallen to negligible levels, and the anti-inflammatory protection it provided is effectively gone.
For most people with healthy liver and kidney function who aren’t taking interacting medications, the full clearance window is about 5 to 7 days. If you have liver impairment or take strong CYP3A4 inhibitors, that window could stretch somewhat longer, though no precise number has been established for those scenarios. The timeline also doesn’t change based on how long you’ve been on the medication; once you stop, the same half-life math applies whether you used Trelegy for a month or a year.